Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

The phase 2 LYSA study of prednisone, vinblastine, doxorubicin, and bendamustine for untreated Hodgkin lymphoma in older patients

Blood (2024) 143 (11): 983–995.

https://doi.org/10.1182/blood.2023021564

Published: 2024

Includes: Supplemental data

Journal Articles

Post-Transplant Lymphoproliferative Disorders (PTLD) in Real Life: Data from the French K-Virogref Registry on 525 Adult Patients

Blood (2023) 142 (Supplement 1): 443.

https://doi.org/10.1182/blood-2023-189133

Published: 2023

Journal Articles

Tislelizumab, an Anti-PD1 Antibody, in Patients with Relapsed/Refractory Classical Hodgkin Lymphoma in Tirhol Bgb-A317-210: A Prospective Multicenter Lysa Phase 2 Study Conducted in Western Countries

Blood (2023) 142 (Supplement 1): 1717.

https://doi.org/10.1182/blood-2023-188545

Published: 2023

Journal Articles

Prednisone, Vinblastine, Doxorubicin and Bendamustine (PVAB) Regimen in First Line Therapy for Older Patients with Advanced-Stage Classical Hodgkin Lymphoma: Results of a Prospective Multicenter Phase II Trial of the Lymphoma Study Association (LYSA)

Herve Ghesquieres, MD PhD, Olivier Casasnovas, MD, Emmanuelle Nicolas-Virelizier, MD, Damaj Gandhi Laurent, MD PhD, Vincent Delwail, MD, Mohamed Touati, MD, Katell Le Du, MD, Franck Morschhauser, MD PhD, Christophe Bonnet, MD, Agathe Waultier-Rascalou, MD, Frederique Orsini-Piocelle, MD, Marc André, Myriam Ben Boutieb, Fabienne Morand, Diane Damotte, MD PhD, Alexandra Traverse-Glehen, MD PhD, Philippe Quittet, MD, Pauline Brice

Blood (2019) 134 (Supplement_1): 2832.

https://doi.org/10.1182/blood-2019-129016

Published: 2019

Journal Articles

PET-Based Response after 2 Cycles of Brentuximab Vedotin in Combination with AVD for First-Line Treatment of Unfavorable Early-Stage Hodgkin Lymphoma: First Analysis of the Primary Endpoint of Breach, a Randomized Phase II Trial of Lysa-FIL-EORTC Intergroup

Blood (2017) 130 (Supplement 1): 736.

https://doi.org/10.1182/blood.V130.Suppl_1.736.736

Published: 2017

Journal Articles

Assessment of Cardiac Iron Overload in Chonically Transfused Patients with Thalassemia, Sickle Cell Anemia, and Myelodysplastic Syndromes

Mariane De Montalembert, MD PhD, Jean-Antoine Ribeil, MD PhD, Valentine Brousse, Agnes Guerci-Bresler, MD, Aspasia Stamatoullas, MD, Jean Pierre Vannier, MD, Agnes Lahary, MD, Mohamed Touati, MD, Krimo Bouabdallah, MD, Marina Cavazzana, MD PhD, Emmanuelle Chauzit, MD, Amandine Baptiste, MD, Thibaud Lefebvre, MD, Herve Puy, MD PhD, Caroline Elie, MD PhD, Zoubida Karim, PhD, Olivier Ernst, MD PhD, Christian Rose

Blood (2015) 126 (23): 2151.

https://doi.org/10.1182/blood.V126.23.2151.2151

Published: 2015

Journal Articles

Management and Outcomes of Nodular Lymphocyte Predominant Hodgkin Lymphoma: A Retrospective Study By the Lymphoma Study Association

Julien Lazarovici, MD, Pauline Brice, MD, Lucie Obéric, MD, Isabelle Gaillard, MD, Mathilde Hunault-Berger, MD PhD, Florence Broussais, MD, Serge Bologna, MD, Emmanuel Gyan, MD PhD, Catherine Sebban, MD, Mohamed Touati, MD, Richard Delarue, MD, Frédérique Orsini-Piocelle, MD, Aspasia Stamatoullas, MD, Peggy Dartigues, MD, Marc PE André, MD, Olivier Casasnovas, MD, Nicolas Mounier, MD PhD, Christophe Fermé, MD

Blood (2014) 124 (21): 3054.

https://doi.org/10.1182/blood.V124.21.3054.3054

Published: 2014

Journal Articles

An Interactive 3D Lymphoma's Stage Calculator Assistant: A New Tool to Help Hematologists in Routine Practice

Mohamed Touati, MD, Jeremy Assenat, Jacques Monteil, MD, Philippe De Souza, MD, Magdalena Munyamahoro, Sandra Juge, Pierre-Marie Preux, MD, Arnaud Jaccard, MD, Dominique Bordessoule, MD

Blood (2014) 124 (21): 1323.

https://doi.org/10.1182/blood.V124.21.1323.1323

Published: 2014

Journal Articles

FDG-PET/CT Metabolic Tumor Volume: A New Prognostic Marker in Hodgkin Lymphoma?

Marine Boulesteix, Mohamed Touati, Julie Abraham, Sandrine Verbeke, Assmae El Badaoui, Marie Pierre Gourin, Agnes Olivrie, Manuela Delage Corre, Benoit Marin, Arnaud Jaccard, Dominique Bordessoule, MD, PhD, Jacques Monteil

Blood (2012) 120 (21): 3632.

https://doi.org/10.1182/blood.V120.21.3632.3632

Published: 2012

Journal Articles

Health Cost Modelisation of Home Versus Hospital Administration of Bortezomib. Experience of a French Hematologic Care Network

Mohamed Touati, Ludovic Lamarsalle, Stephane Moreau, Sophie Lefort, Liliane Remenieras, Catherine Brillat, Francoise Vergnenegre, Aline Lagarde, Annick Daulange, Véronique Gatard, Alain Vergnenegre, Dominique Bordessoule, MD, PhD

Blood (2012) 120 (21): 4233.

https://doi.org/10.1182/blood.V120.21.4233.4233

Published: 2012

Journal Articles

CD68+ Tumor-Associated Macrophages Predict Unfavorable Treatment Outcomes in Classic Hodgkin's Lymphoma in Correlation with Early FDG-PET Assessment Results

Mohamed Touati, Manuela Delage-Corre, Jacques Monteil, Agnes Olivrie-Gamaury, Stephane Moreau, Liliane Remenieras, Marie-Pierre Gourin, Julie Abraham, Nataliya Dmytruk, Arnaud Jaccard, Dominique Bordessoule

Blood (2011) 118 (21): 1558.

https://doi.org/10.1182/blood.V118.21.1558.1558

Published: 2011

Journal Articles

0utpatient and Home Chemotherapy: Preliminary Results of the Experience of the Limousin (France) Hematological Care Network.

Mohamed Touati, Liliane Remenieras, Stephane Moreau, eronique Truffinet, V, Sophie Lefort, Francoise ergnenegre, V, Mona Abouelfadel, Aline Lagarde, Agnes Cournede, Annick Daulange, Marie-Charlotte Laffetas, Dominique Bordessoule

Blood (2010) 116 (21): 3823.

https://doi.org/10.1182/blood.V116.21.3823.3823

Published: 2010

Journal Articles

“Non-Hodgkin's Lymphomas and Diabetes of Type 2 in Elderly Patients: Impact On Management in the Real Life”.

Stephane Moreau, Liliane Remenieras, Mohamed Touati, Marie Jose RAPP, Marie-Pierre Gourin, Frederica Bompart, Nicolas Weinbreck, Sophie Lefort, Dominique Devesa-Mansour, Jean Feuillard, Arnaud Jaccard, Dominique Bordessoule, MD, PhD

Blood (2009) 114 (22): 4998.

https://doi.org/10.1182/blood.V114.22.4998.4998

Published: 2009

Journal Articles

Improved Survival in Recent Years of Chronic Myeloid Leukemia (CML) Observed in the Real World in a Cohort of Patients Cared in a Haematological Regional Network HEMATOLIM.

Pascal Turlure, Nathalie Gachard, Marie-Pierre Gourin, Stéphane Girault, Mohamed Touati, Liliane Remenieras, Stephane Moreau, Celine Philippon, Sophie Lefort, Jean Feuillard, Dominique Bordessoule

Blood (2009) 114 (22): 4283.

https://doi.org/10.1182/blood.V114.22.4283.4283

Published: 2009

Journal Articles

X-Linked Sideroblastic Anemia Is a Rare Cause of Microcytosis and Iron Overload in Adults: About 3 Cases with 2 New ALAS2 Gene Mutations Improved after Iron Chelation by Phlebotomy.

Mohamed Touati, Franck Trimoreau, Marie-Pierre Gourin-Chaury, Caroline Kannengiesser, Pascal Turlure, Veronique Loustaud-Ratti, Brigitte Gilbert-Dussardier, Bernard Grandchamp, Dominique Bordessoule

Blood (2007) 110 (11): 4619.

https://doi.org/10.1182/blood.V110.11.4619.4619

Published: 2007

NARROW

The phase 2 LYSA study of prednisone, vinblastine, doxorubicin, and bendamustine for untreated Hodgkin lymphoma in older patients

Post-Transplant Lymphoproliferative Disorders (PTLD) in Real Life: Data from the French K-Virogref Registry on 525 Adult Patients

Tislelizumab, an Anti-PD1 Antibody, in Patients with Relapsed/Refractory Classical Hodgkin Lymphoma in Tirhol Bgb-A317-210: A Prospective Multicenter Lysa Phase 2 Study Conducted in Western Countries

Prednisone, Vinblastine, Doxorubicin and Bendamustine (PVAB) Regimen in First Line Therapy for Older Patients with Advanced-Stage Classical Hodgkin Lymphoma: Results of a Prospective Multicenter Phase II Trial of the Lymphoma Study Association (LYSA)

PET-Based Response after 2 Cycles of Brentuximab Vedotin in Combination with AVD for First-Line Treatment of Unfavorable Early-Stage Hodgkin Lymphoma: First Analysis of the Primary Endpoint of Breach, a Randomized Phase II Trial of Lysa-FIL-EORTC Intergroup

Assessment of Cardiac Iron Overload in Chonically Transfused Patients with Thalassemia, Sickle Cell Anemia, and Myelodysplastic Syndromes

Management and Outcomes of Nodular Lymphocyte Predominant Hodgkin Lymphoma: A Retrospective Study By the Lymphoma Study Association

An Interactive 3D Lymphoma's Stage Calculator Assistant: A New Tool to Help Hematologists in Routine Practice

FDG-PET/CT Metabolic Tumor Volume: A New Prognostic Marker in Hodgkin Lymphoma?

Health Cost Modelisation of Home Versus Hospital Administration of Bortezomib. Experience of a French Hematologic Care Network

CD68+ Tumor-Associated Macrophages Predict Unfavorable Treatment Outcomes in Classic Hodgkin's Lymphoma in Correlation with Early FDG-PET Assessment Results

0utpatient and Home Chemotherapy: Preliminary Results of the Experience of the Limousin (France) Hematological Care Network.

“Non-Hodgkin's Lymphomas and Diabetes of Type 2 in Elderly Patients: Impact On Management in the Real Life”.

Improved Survival in Recent Years of Chronic Myeloid Leukemia (CML) Observed in the Real World in a Cohort of Patients Cared in a Haematological Regional Network HEMATOLIM.

X-Linked Sideroblastic Anemia Is a Rare Cause of Microcytosis and Iron Overload in Adults: About 3 Cases with 2 New ALAS2 Gene Mutations Improved after Iron Chelation by Phlebotomy.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only